Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04225624 · ClinicalTrials.gov registry record · NA
Improving Attentional and Cognitive Control in the Psychological Treatment of Intrusive Thoughts
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT04225624: Completed NA study, sponsored by Massachusetts General Hospital.
NCT04225624 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04225624, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
The investigators are conducting this study to learn more about the cognitive and attentional processes among individuals with three types of repetitive negative thinking (RNT): mental rituals (as seen in obsessive compulsive disorder, OCD), worries (as seen in generalized anxiety disorder, GAD), and ruminations (as seen in major depressive disorder, MDD). Specifically, the investigators are studying whether psychological treatment can help people with RNT who have trouble stopping unwanted thoughts and shifting their attention.
Interventions
- BEHAVIORAL Supportive Psychotherapy (SPT)
- BEHAVIORAL Emotion Regulation Therapy - Attention Regulation (AR-ERT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2021-04-30 |
| Est. Completion | 2025-04-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04225624
The ClinicalTrials.gov registry entry for NCT04225624 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Supportive Psychotherapy (SPT) is the first listed.
NCT04225624 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04225624 about?
NCT04225624 is a clinical study titled "Improving Attentional and Cognitive Control in the Psychological Treatment of Intrusive Thoughts". The investigators are conducting this study to learn more about the cognitive and attentional processes among individuals with three types of repetitive negative thinking (RNT): mental rituals (as seen in obsessive compulsive disorder, OCD), worries (as seen in generalized anxiety disorder, GAD), an...
What is the current status of trial NCT04225624?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2021-04-30. Estimated completion is 2025-04-09.
What interventions are being tested in trial NCT04225624?
The interventions under investigation include: Supportive Psychotherapy (SPT) (BEHAVIORAL), Emotion Regulation Therapy - Attention Regulation (AR-ERT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04225624?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.